Table 2.
Characteristics of the study population in three (3) separate groups.
| Different Variables | Group 1- STV N (%) |
Group 2- PLC N (%) |
Group 3- CL N (%) |
Total Participants N (%) |
|
|---|---|---|---|---|---|
| Body Mass Index (BMI) | |||||
| Underweight | 1 (2.3%) | 1 (2.3%) | 0 (0.00%) | 2 (2.1%) | |
| Normal | 16 (36.4%) | 15 (34.9%) | 4 (40%) | 35 (36.1%) | |
| Overweight | 19 (43.2%) | 22 (51.2%) | 5 (50%) | 46 (47.4%) | |
| Obese | 8 (18.2%) | 5 (11.6%) | 1 (10%) | 14 (14.4%) | |
| Stages of CKD (GFR: ml/minutes/1.73 m2)a | |||||
| Stage-I | 5 (11.4%) | 4 (9.3%) | 0 (0%) | 16 (16.5%) | |
| Stage-II | 23(52.3%) | 13 (30.2%) | 0 (0%) | 39 (40.2%) | |
| Stage-III | 16(36.4%) | 26 (60.5%) | 0 (0%) | 42 (43.3%) | |
| No. of Affected family members | |||||
| One (1) | 13 (29.5%) | 5 (11.6%) | 1 (10.0%) | 19 (19.6%) | |
| More than one (1) | 1 (2.3%) | 1 (2.3%) | 0 (0.0%) | 2 (2.1%) | |
| No | 30 (68.2%) | 37 (86.0%) | 9 (90.0%) | 76 (78.4%) | |
| History of Smoking & Alcohol Intake | |||||
| Smoking | YES | 16 (47.1%) | 15 (44.1%) | 3 (8.8%) | 34 (100%) |
| NO | 28 (44.4%) | 28 (44.4%) | 7 (11.1) | 63 (100%) | |
| Alcohol | YES | 1 (33.3) | 2 (66.7%) | 0 (0.0%) | 3 (100%) |
| NO | 43 (45.7%) | 41 (43.6%) | 10 (10.6%) | 94 (100%) | |
Group I- STV= Stevia (n = 44), Group II- PLC= Placebo (n = 43) and Group III- CL= Control (n = 10). Descriptive analysis was performed here. Range of BMI: Underweight = BMI (below 18.5), Normal = BMI (18.5–24.9), Overweight = BMI (25–29.9), Obese = BMI (30+). Different Stages of CKD: Stage I = eGFR 90 ml/min/1.73 m2 or higher, Stage II = eGFR 60–89 ml/min/1.73 m2, Stage III = eGFR 30–59 ml/min/1.73 m2.
a
National Kidney Foundation (NKF) 2002.